Company / Free Cash Flow
Progyny Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$191.8M
FY2025
5-year range
$23.9M / $191.8M
FY2021-FY2025
Trend
+10.4%
vs FY2024
Sector context
#65 of 145
Health Care
What the data says
At $192M, Progyny's free cash flow ranks #65 of 145 in the Health Care sector. Free Cash Flow has fluctuated over the past 9 years, ranging from -$10M in FY2017 to $192M in FY2025.
Based on SEC 10-K filings.
$192M in FY2025 with a 5-year CAGR of +40.4%.
Improved from $185M to $192M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +35.5%
- 5-Year CAGR
- +40.4%
- 10-Year CAGR
- -
Sector benchmark
#65 of 145 in Health CareTop 45% of 145This company $191.8M Sector average $770.9M
▼
-75.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.4%, indicating consistent growth.
- In FY2025, free cash flow increased 10.4% year-over-year.
- Ranks #65 out of 145 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $191.8M | +10.4% |
| FY2024 | $173.7M | -6.2% |
| FY2023 | $185.2M | +140.0% |
| FY2022 | $77.2M | +222.7% |
| FY2021 | $23.9M | -32.0% |
| FY2020 | $35.2M | +883.2% |
| FY2019 | -$4.5M | -365.2% |
| FY2018 | $1.7M | +116.8% |
| FY2017 | -$10.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026